
<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>pmc: PMC1598857 , PMC1607934
Over 13 months 118 patients admitted to hospital with acute stroke were allocated at random to treatment with either dexamethasone or placebo. At one year there was no significant difference in the numbers of survivors or in the quality of life between the two groups. The results suggest that there is no indication for the routine administration of dexamethasone to a heterogeneous group of patients with stroke.
Male, Publishing, Clinical Trials as Topic, Time Factors, Hydrocortisone, Injections, Intramuscular, Dexamethasone, Random Allocation, Cerebrovascular Disorders, Double-Blind Method, Acute Disease, Potassium, Humans, Female
Male, Publishing, Clinical Trials as Topic, Time Factors, Hydrocortisone, Injections, Intramuscular, Dexamethasone, Random Allocation, Cerebrovascular Disorders, Double-Blind Method, Acute Disease, Potassium, Humans, Female
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 108 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 1% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
